These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 16178882)

  • 21. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp.
    Kook JH; Kim HJ; Kim KW; Park SJ; Kim TH; Lim SH; Kang SH; Lee SH
    Am J Rhinol Allergy; 2015; 29(4):246-50. PubMed ID: 26163245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
    Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
    J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE; Walker BR
    J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.
    Stulnig TM; Waldhäusl W
    Diabetologia; 2004 Jan; 47(1):1-11. PubMed ID: 14652720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of 11β-HSDs, GR, and H6PDH in subcutaneous adipose tissue from polycystic ovary syndrome subjects.
    Li S; Tao T; Wang L; Mao X; Zheng J; Zhao A; Liu W
    Horm Metab Res; 2013 Oct; 45(11):802-7. PubMed ID: 23979790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local and systemic glucocorticoid metabolism in inflammatory arthritis.
    Hardy R; Rabbitt EH; Filer A; Emery P; Hewison M; Stewart PM; Gittoes NJ; Buckley CD; Raza K; Cooper MS
    Ann Rheum Dis; 2008 Sep; 67(9):1204-10. PubMed ID: 18420938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR
    Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1.
    Biedasek K; Andres J; Mai K; Adams S; Spuler S; Fielitz J; Spranger J
    PLoS One; 2011 Jan; 6(1):e16674. PubMed ID: 21304964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 11β-hydroxysteroid dehydrogenase types 1 and 2 activity in subcutaneous adipose tissue in humans: implications in obesity and diabetes.
    Dube S; Norby BJ; Pattan V; Carter RE; Basu A; Basu R
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E70-6. PubMed ID: 25303491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.
    Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ
    J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of 11β-hydroxysteroid dehydrogenase enzymes in human osteosarcoma: potential role in pathogenesis and as targets for treatments.
    Patel P; Hardy R; Sumathi V; Bartle G; Kindblom LG; Grimer R; Bujalska I; Stewart PM; Rabbitt E; Gittoes NJ; Cooper MS
    Endocr Relat Cancer; 2012 Aug; 19(4):589-98. PubMed ID: 22719058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action.
    Seckl JR
    Curr Opin Pharmacol; 2004 Dec; 4(6):597-602. PubMed ID: 15525550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-diabetic and anti-inflammatory effect of a novel selective 11β-HSD1 inhibitor in the diet-induced obese mice.
    Park SB; Jung WH; Kang NS; Park JS; Bae GH; Kim HY; Rhee SD; Kang SK; Ahn JH; Jeong HG; Kim KY
    Eur J Pharmacol; 2013 Dec; 721(1-3):70-9. PubMed ID: 24135201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
    Morgan SA; Sherlock M; Gathercole LL; Lavery GG; Lenaghan C; Bujalska IJ; Laber D; Yu A; Convey G; Mayers R; Hegyi K; Sethi JK; Stewart PM; Smith DM; Tomlinson JW
    Diabetes; 2009 Nov; 58(11):2506-15. PubMed ID: 19675138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
    Wang M
    Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
    Pereira CD; Azevedo I; Monteiro R; Martins MJ
    Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of hyperlipidemia on 11β-hydroxysteroid-dehydrogenase, glucocorticoid receptor, and leptin expression in insulin-sensitive tissues of cats.
    Sieber-Ruckstuhl NS; Zini E; Osto M; Franchini M; Boretti FS; Meli ML; Sigrist B; Lutz TA; Reusch CE
    Domest Anim Endocrinol; 2010 Nov; 39(4):222-30. PubMed ID: 20688460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344).
    Park JS; Rhee SD; Kang NS; Jung WH; Kim HY; Kim JH; Kang SK; Cheon HG; Ahn JH; Kim KY
    Biochem Pharmacol; 2011 Apr; 81(8):1028-35. PubMed ID: 21315688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development.
    Thompson A; Han VK; Yang K
    J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):367-75. PubMed ID: 15145446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.